原著論文
英文
-
Clinical characteristics of cancer-associated myositis complicated by interstitial lung disease: a large-scale multicentre cohort study
Kaneko Y, Nunokawa T, Taniguchi Y, Yamaguchi Y, Gono T, Masui K, Kawakami A, Kawaguchi Y, Sato S and Kuwana M; JAMI investigators.
Rheumatology (Oxford). 2020; 59(1):112-119. -
Comparison of cytokine profiles between anti-ARS antibody-positive interstitial lung diseases and those with anti-MDA-5 antibodies
Asakawa K, Yoshizawa K, Aoki A, Kimura Y, Tanaka T, Ohashi K, Hayashi M, Kikuchi T, Sato S, Takada T.
Clin Rheumatol. 2020;39(7):2171-2178. -
Clinical, radiological, and pathological features of anti-asparaginyl tRNA synthetase antibody-related interstitial lung disease
Aiko N, Yamakawa H, Iwasawa T, Takemura T, Okudela K, Kitamura H, Hagiwara E, Ikeda S, Baba T, Iso S, Yamaguchi Y, Kondo Y, Kurabayashi T, Ohashi K, Sato S, Ogura T.
Respir Investig. 2020;58(3):196-203. -
Seasonal and residential clustering at disease onset of anti-MDA5-associated interstitial lung disease
Nishina N, Sato S, Masui K, Gono T, Kuwana M.
RMD Open. 2020;6(2):e001202. -
Evaluation of usefulness in surfactant protein D as a predictor of mortality in myositis-associated interstitial lung disease
Kaieda S, Gono T, Masui K, Nishina N, Sato S, Kuwana M, A Multicenter Retrospective Cohort of Japanese Patients with Myositis-associated ILD (JAMI) investigators.
PLoS One. 2020 Jun 11;15(6):e0234523.doi: 10.1371. -
Clinicopathological evaluation of methotrexate-associated lymphoproliferative disorders with special focus on Epstein-Barr virus-positive mucocutaneous lesions
Shiraiwa S, Kikuti YY, Carreras J, Hara R, Aoyama Y, Ogiya D, Suzuki R, Toyosaki M, Ohmachi K, Ogawa Y, Kawada H, Sato S, Nakamura N, Ando K.
J Clin Exp Hematop. 2020 Dec 15;60(4):159-168. doi: 10.3960/jslrt.20041. Epub 2020 Nov 4. PMID: 33148934. -
Emerging Therapeutics in Idiopathic Inflammatory Myopathy
Sato S.
Indian J Rheumatol. 2020. DOI: 10.4103/injr.injr_124_20.
学会発表
国際
-
The management of rapidly progressive interstitial lung disease associated with clinically amyopathic dermatomyositis in Japans
Sato S.
APLAR. 2020.10 -
Pharmacodynamics of methotrexate as methotrexate-polyglutamates concentrations in rheumatoid arthritis; interim data from MIRACLE Study conducted in Japan, Korea and Taiwan
Tamai H, Kaneko Y, Kameda H, Kuwana M, Okano Y, Ishii T, Ikeda K, Taguchi H, Sato S, Miyamoto T, Sugiyama E, Yasuoka H, Kojima T, Park S. H., Shin K, Baek H. J., Lee Y. J., Choi I. A., Kim J, Hsu P, Kuo C, Huang C, Weng M, Tsai W, Cheng T, Taninaga T, Mori M, Miyagishi H, Sato Y, Takeuchi T.
APLAR. 2020.10 -
Efficacy of Early Initiation of Plasma Exchange Therapy for a Patient with Anti-MDA5 Autoantibody-Positive Dermatomyositis Developing Refractory Rapidly Progressive Interstitial Lung Disease
Sasaki N, Ishii A, Shimura K, Kojima A, Sugiyama M, Nakagome Y, Izumi Y, Hirano K, Sasaki S, Kurabayashi T, Hosono Y, Yamada C, Sato S.
The 2020 Annual scientific meeting of American College of Rheumatology. 2020.11
